1. Booth B, Weiss W, Koerzum HA, Wood WC, Cary RW, Panasei LC (1985) Phase II trial of carboplatin in advanced breast carcinoma —Cancer and Leukemia Group B study. Cancer Treat Rep 69: 919–920
2. Carmo-Pereira J, Oliveira-Costa F, Rubens RD (1989) Carboplatin as primary chemotherapy for disseminated breast cancer — a phase II study. In: ECCO-5 Abstracts. London, 3–7 September
3. Franks CR, Nys G, Schultz HP, Schmoll HJ, Canneta R, Rozenzweig M (1986) Randomized phase II trial of carboplatin vs iproplatin in solid tumors. Proc Am Soc Clin Oncol 5: 129
4. Kolarić K, Roth A (1983) Phase II clinical trial ofcis-dichlorodiammine platinum (Cis DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer. Cancer Chemother Pharmacol 11: 108–112
5. Kolarić K, Vukas D, Roth A (1984) CAP (cyclophosphamide, Adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. Cancer Chemother Pharmacol 13: 142–145